Welcome to LookChem.com Sign In|Join Free
  • or
N-(4-BROMOPHENYL)-4-CHLOROBUTANAMIDE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

300395-07-7

Post Buying Request

300395-07-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

300395-07-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 300395-07-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,0,3,9 and 5 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 300395-07:
(8*3)+(7*0)+(6*0)+(5*3)+(4*9)+(3*5)+(2*0)+(1*7)=97
97 % 10 = 7
So 300395-07-7 is a valid CAS Registry Number.

300395-07-7Relevant academic research and scientific papers

A one pot protocol to convert nitro-arenes into: N-aryl amides

Massolo, Elisabetta,Pirola, Margherita,Puglisi, Alessandra,Rossi, Sergio,Benaglia, Maurizio

, p. 4040 - 4044 (2020/02/04)

A two-step one pot, experimentally simple protocol, based on readily available and inexpensive reagents allowed the conversion of nitro-arenes directly to N-aryl amides. A metal-free reduction of the nitro group, mediated by trichlorosilane, followed by the addition of an anhydride afforded the corresponding N-aryl carboxyamide, that was isolated after a simple aqueous work up in good-excellent yields. When the methodology was applied to the reaction with γ-butyrolactone, the desired N-aryl butanamide derivative was obtained, featuring a chlorine atom at the γ-position, a functionalized handle that can be used for further synthetic manipulation of the reaction product. Such an intermediate has already been employed as a key advanced precursor of pharmaceutically active compounds.

LACTAMS AS INHIBITORS OF ROCK

-

Page/Page column 116, (2016/09/26)

The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 300395-07-7